COVID-19 VACCINES SA PINAS, SUMAMPA NA SA 100M

0

KULANG-KULANG 100 milyong doses ng coronavirus disease 2019 (COVID-19) vaccines ang binili ng gobyerno at donasyon sa Pilipinas.

Sinabi ni National Task Force (NTF) Against COVID-19 chief implementer, Secretary Carlito Galvez Jr., “as of October 22,” nakatanggap ang bansa ng 94,687,340 doses ng iba’t ibang brands ng bakuna gaya ng Sinovac at Sinopharm mula China; Sputnik V mula Russia; AstraZeneca mula United Kingdom; at Pfizer, Moderna, at Johnson&Johnson mula Estados Unidos.

“Yes, because this coming Sunday we will be receiving another three million. We are nearing that mark. We only need 2.3 million and there are still donations that are coming in. There’s also another Sputnik V that is coming, also donations from (the) US that will be coming in, two million-plus, and also some of the donations of other countries,” ani Galvez sa isang panayam matapos dumating sa bansa ang 1,014,390 doses ng Pfizer vaccine sa Terminal 3 ng Ninoy Aquino International Airport (NAIA) sa Pasay City.

Ang Pfizer vaccine ay binili ng pamahalaan sa pamamagitan ng Asian Development Bank.

Sa kabilang dako, pinasalamatan naman ni Galvez ang US government para sa vaccine delivery.

“We are very thankful that almost every day, we are receiving vaccines, and majority of which is coming from the US. Again, (on) behalf of the NTF, we would like to thank Pfizer and also the US government for continuously giving us this access and the deliveries,” anito. (CHRISTIAN DALE)

 
"COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by SAKSI NGAYON. Comments are views by saksingayon.com readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of saksingayon.com. While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with SAKSI NGAYON editorial standards, SAKSI NGAYON may not be held liable for any false information posted by readers in this comments section."

Related posts

Leave a Comment